Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry

Smith, 2000, Epidemiology of lung cancer, Radiol. Clin. North Am., 38, 453, 10.1016/S0033-8389(05)70176-7 Hirsch, 2001, Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology, Clin. Cancer Res., 7, 5 Tockman, 1986, Survival and mortality from lung cancer in a screened population—the Johns Hopkins Study, Chest, 89, 324S, 10.1378/chest.89.4_Supplement.324S-a Henchke, 1999, Early Lung Cancer Action Project: overall design and findings from baseline screening, Lancet, 354, 99, 10.1016/S0140-6736(99)06093-6 Vazquez, 2000, Small peripheral glandular lesions detected by screening CT for lung cancer. A diagnostic dilemma for the pathologist, Radiol. Clin. North Am., 38, 579, 10.1016/S0033-8389(05)70186-X Markers of Transformation in Airways Epithelial Cells from a Cohort of Obstructed Smokers and Former Smokers. Ongoing Clinical Trial at the Moffitt Cancer Center, PI. M. Tockman, 2002. Kvale PA. Lung cancer and solitary pulmonary nodule. The ACCP Pulmonary Board Review 2000;157–72. Hirsch, 2001, Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology, Clin. Cancer Res., 7, 5 Simone, 1998, Laser-capture microdissection: opening the microscopic frontier to molecular analysis, Elsevier Trends J., Trends Genet., 14, 272, 10.1016/S0168-9525(98)01489-9 Hutchens, 1993, New desorption strategies for the mass spectrometric analysis of macromolecules, Rapid Commun. Mass Spectrom., 7, 576, 10.1002/rcm.1290070703 Wright, 1999, ProteinChip surface enhanced laser desorption/ionization mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures, Prostate Cancer Prostate Dis., 2, 264, 10.1038/sj.pcan.4500384 Brambilla, 2001, The new World Health Organization classification of lung tumours, Eur. Respir. J., 18, 1059, 10.1183/09031936.01.00275301 Kitamura, 1997, Cytodifferentiation of atypical adenomatous hyperplasia and bronchioloalveolar lung carcinoma: immunohistochemical and ultrastructural studies, Virchows Arch., 431, 415, 10.1007/s004280050118 Kerr, 1994, Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression, J. Pathol. (London), 174, 249, 10.1002/path.1711740404 Nakayama, 1990, Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content, Modern Pathol., 3, 314 Shimosato, 1994, Pulmonary neoplasms, 1045 Emmert-Buck, 1996, Laser capture microdissection, Science (Washington, DC), 274, 998, 10.1126/science.274.5289.998 Hanash, 2001, A proteomic approach to the identification of lung cancer markers, Disease Mark., 17, 295, 10.1155/2001/657605 Oh, 2001, A database of protein expression in lung cancer, Proteomics, 1, 1303, 10.1002/1615-9861(200110)1:10<1303::AID-PROT1303>3.0.CO;2-2 Yamamoto, 1996, Detection of auto-antibodies against l-myc oncogene products in sera from lung cancer patients, Int. J. Cancer, 22, 283, 10.1002/(SICI)1097-0215(19960822)69:4<283::AID-IJC8>3.0.CO;2-T Petricoin, 2002, Use of proteomic patterns in serum to identify ovarian cancer, Lancet, 359, 572, 10.1016/S0140-6736(02)07746-2 Vlahou, 2001, Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine, Am. J. Pathol., 158, 1491, 10.1016/S0002-9440(10)64100-4 Le Naour, 2001, Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer, Clin. Cancer Res., 7, 3328 Tockman, 1988, Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection, J. Clin. Oncol., 6, 1685, 10.1200/JCO.1988.6.11.1685 Tockman, 1997, Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression, Clin. Cancer Res., 3, 2237 Tockman, 1998, Antigen retrieval improves hnRNP A2/B1 immunohistochemical localization in premalignant lesions of the lung, 239 Zhukov TA, Erozan YS, Tockman MS. Sentinel cell for lung cancer. The 14th International Congress of Cytology, Amsterdam, The Netherland, 27–31 May 2001. p. 352. Niklinski, 2001, Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications, Eur. J. Cancer Preven., 10, 213, 10.1097/00008469-200106000-00004 Carey, 1992, Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases, Thorax, 47, 1041, 10.1136/thx.47.12.1041 Kerr, 1994, Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression, J. Pathol. (London), 174, 249, 10.1002/path.1711740404 Yankelevitz, 1997, Does 2-year stability imply pulmonary nodules are benign?, Am. J. Roentgenol., 168, 325, 10.2214/ajr.168.2.9016198 Liotta, 2001, Clinical proteomics: personalized molecular medicine, J. Am. Med. Assoc., 286, 2211, 10.1001/jama.286.18.2211